InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Discover the detailed record of transactions filed by Turner Kathy V, Vice-Présidente Senior. Officer active across 1 companies, notably Idexx Laboratories INC /de. Cumulatively, 14 reports have been published. Total volume traded: €5.3m. The latest transaction was filed on 18 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
€87,9881,474 shares@ €59.69310.0002% mcap1.6% of flow
Common Stock
SEC:0001567619-22-005274:0·
0211 shares0
Common Stock
SEC:0001567619-22-004787:0·
€84,5891,256 shares@ €67.34810.0002% mcap3.0% of flow
Common Stock
SEC:0001567619-21-016671·
€84,5891,256 shares@ €67.34810.0002% mcap1.5% of flow
Common Stock
SEC:0001567619-21-016671:0·
€915,9902,000 shares@ €457.99510.0017% mcap33.0% of flow
Common Stock
SEC:0001567619-21-016515·
€15,081276 shares@ €54.64250.0000% mcap0.5% of flow
Common Stock
SEC:0001567619-21-016516·
€915,9902,000 shares@ €457.99510.0017% mcap16.3% of flow
Common Stock
SEC:0001567619-21-016515:0·
€15,081276 shares@ €54.64250.0000% mcap0.3% of flow
Common Stock
SEC:0001567619-21-016516:0·
€915,9902,000 shares@ €457.99510.0017% mcap33.0% of flow
Common Stock
SEC:0001567619-21-011455·
€915,9902,000 shares@ €457.99510.0017% mcap16.3% of flow
Common Stock
SEC:0001567619-21-011455:0·
€404,515900 shares@ €449.46080.0008% mcap14.6% of flow
Common Stock
SEC:0001567619-21-011202·
€404,515900 shares@ €449.46080.0008% mcap7.2% of flow
Common Stock
SEC:0001567619-21-011202:0·
€437,6141,000 shares@ €437.6140.0008% mcap15.8% of flow
Common Stock
SEC:0001567619-21-011068·
€437,6141,000 shares@ €437.6140.0008% mcap7.8% of flow
Common Stock
SEC:0001567619-21-011068:0·
14 of 14 declarations
About Turner Kathy V
Kathy V. Turner is the Senior Vice President at IDEXX LABORATORIES INC. In this role, she is responsible for the strategic and operational leadership of the company, which specializes in veterinary diagnostics. Kathy V. Turner plays a key role in managing teams and optimizing processes to ensure customer satisfaction. Her expertise in the life sciences sector is an asset to the company.
